Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis

Annals of Surgery

Volumn 248, Issue 2, 2008, Pages 286-293

  Spillane, Andrew J ^a,b,c   Saw, Robyn P M ^a,b   Tucker, Monica ^a   Byth, Karen ^b   Thompson, John F ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MELANOMA INSTITUTE AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; POLYVALENT VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER REGRESSION; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; ILIOINGUINAL LYMPH NODE DISSECTION; INFRARED SPECTROMETRY; INGUINAL LYMPHADENECTOMY; LEG; LIMB; LOWER LIMB LYMPHEDEMA; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTATIC MELANOMA; PATIENT ASSESSMENT; PERCEPTIVE THRESHOLD; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; VOLUMETRY; CANCER STAGING; CLASSIFICATION; CONFIDENCE INTERVAL; HOSPITALIZATION; INGUINAL CANAL; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; SKIN TUMOR; SURVIVAL;

ADULT; AGED; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; INGUINAL CANAL; LOWER EXTREMITY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHEDEMA; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 49849105296     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31817ed7c3     Document Type: Article

References (23)

1. Starritt EC, Joseph D, McKinnon G, et al. Lymphedema after complete axillary node dissection for melanoma. Assessment using a new, objective definition. Ann Surg. 2004;240:5:866-874.
2. Serpell JW, Carne PWG, Bailey M. Radical lymph node dissection for melanoma. ANZJ Surg. 2003;73:294-299.
3. Hughes TMD, Thomas JM. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86:1493-1498.
4. Karakousis CP, Driscoll DL. Groin dissection in malignant melanoma. Br J Surg. 1994;81:1771-1774.
5. Urist MM, Maddox WA, Kennedy JE, et al. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer. 1983;51:2152-2156.
6. Holmes EC, Moseley HS, Morton DL, et al. A rational approach to the surgical management of melanoma. Ann Surg. 1977;186:481-490.
7. Shaw JHF, Rumball EM. Complications and local recurrence following lymphadenectomy. Br JSurg. 1990;77:760-764.
8. Burmeister BH, Smithers BM, Davis S, et al. Radiation therapy following nodal surgery for melanoma: an analysis oflate toxicity. ANZ J Surg. 2002;72:344-348.
9. Hughes TMD, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87:892-901.
10. Baas PC, Schraffordt Koops H, Hoekstra HJ, et al. Groin dissection in the treatment of lower extremity melanoma. Short-term and long-term morbidity. Arch Surg. 1992;127:282-286.
11. James JH. Lymphoedema following ilio-inguinal lymph node dissection. Scand J Plast Reconstr Surg. 1982;16:167-171.
12. Surgery of the Primary Lesion and Nodal Dissections in Malignant Melanoma in Atlas of Surgical Oncology. Philadelphia: WB Saunders Company; 1995:93-128.
13. Kettle JH, Rundle FF, Oddie TH. Measurement of upper limb volumes: a clinical method. AustNZ J Surg. 1958;27:263-270.
14. Breiman L, Friedman JH, Olshen RA, et al. Classification and Regression Trees. Belmont: Wadsworth International Group; 1984.
15. Tobin MB, Lacey HJ, Meyer L, et al. The psychological morbidity of breast cancer related arm swelling. Cancer. 1993;72:3248 -3252.
16. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphed- ema. Cancer. 1998;83:2776-2781.
17. Karlsson P, Holmberg E, Samuelsson A, et al. Soft tissue sarcoma after treatment for breast cancer-a Swedish population based study. Eur J Cancer. 1998;34:2068-2075.
18. Bisceglia M, Attino V, D'Addetta C, et al. Early stage Stewart-Treves syndrome: report of two cases and review of the literature. Pathologica. 1996;88:483-490.
19. de Vries M, Vonkeman WG, van Ginkel RJ, et al. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur JSurg Oncol. 2006;32:785-789.
20. Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20:4242-4248.
21. Creagan ET, Cupps RE, Ivins JC, et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma:A randomized prospective study. Cancer. 1978;42:2206-2210.
22. http://clinicaltrials.gov/show/NCT00287196.
23. Warren AG, Janz BA, Slavin SA, et al. The use of bioimpedance analysis to evaluate lymphedema. Ann Plast Surg. 2007;58:541-543.